BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 27291096)

  • 1. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis.
    Tsujimoto K; Hata A; Fujita M; Hatachi S; Yagita M
    Int J Rheum Dis; 2018 Jul; 21(7):1406-1413. PubMed ID: 27291096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early diagnostic value of Presepsin in sepsis: a prospective study on a population with suspected sepsis in fever clinics].
    Zong X; Liu Y; Gu L; Chen X; Yang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Apr; 36(4):340-344. PubMed ID: 38813625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.
    Papp M; Tornai T; Vitalis Z; Tornai I; Tornai D; Dinya T; Sumegi A; Antal-Szalmas P
    World J Gastroenterol; 2016 Nov; 22(41):9172-9185. PubMed ID: 27895404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis.
    Leli C; Ferranti M; Marrano U; Al Dhahab ZS; Bozza S; Cenci E; Mencacci A
    J Med Microbiol; 2016 Aug; 65(8):713-719. PubMed ID: 27170331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of presepsin in diagnosis and risk stratification for the emergency patients with sepsis.
    Lu B; Zhang Y; Li C; Liu C; Yao Y; Su M; Shou S
    Am J Emerg Med; 2018 Aug; 36(8):1341-1345. PubMed ID: 29276032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
    Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
    Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population.
    Kweon OJ; Choi JH; Park SK; Park AJ
    J Crit Care; 2014 Dec; 29(6):965-70. PubMed ID: 25042676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot Study of Changes in Presepsin Concentrations Compared With Changes in Procalcitonin and C-Reactive Protein Concentrations After Cardiovascular Surgery.
    Saito J; Hashiba E; Mikami A; Kudo T; Niwa H; Hirota K
    J Cardiothorac Vasc Anesth; 2017 Aug; 31(4):1262-1267. PubMed ID: 28431809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Evaluation of Plasma Concentrations of Presepsin in Patients after Severe Trauma: A Prospective Observational Study.
    Koch C; Ruhrmann S; Pöhlmann M; Schneck E; Arneth B; Zajonz T; Sander M; Weigand MA; Uhle F
    Surg Infect (Larchmt); 2018 Jul; 19(5):480-487. PubMed ID: 29683405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of presepsin and procalcitonin for prediction of SeptiFast results in critically ill patients.
    Mihajlovic D; Brkic S; Uvelin A; Draskovic B; Vrsajkov V
    J Crit Care; 2017 Aug; 40():197-201. PubMed ID: 28432884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units.
    Takahashi W; Nakada TA; Yazaki M; Oda S
    Shock; 2016 Sep; 46(3):254-60. PubMed ID: 27172160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presepsin as a predictor of septic shock in patients with urinary tract infection.
    Sekine Y; Kotani K; Oka D; Nakayama H; Miyazawa Y; Syuto T; Arai S; Nomura M; Koike H; Matsui H; Shibata Y; Murakami M; Suzuki K
    BMC Urol; 2021 Oct; 21(1):144. PubMed ID: 34641833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.
    Behnes M; Bertsch T; Lepiorz D; Lang S; Trinkmann F; Brueckmann M; Borggrefe M; Hoffmann U
    Crit Care; 2014 Sep; 18(5):507. PubMed ID: 25190134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies.
    Ebihara Y; Kobayashi K; Ishida A; Maeda T; Takahashi N; Taji Y; Asou N; Ikebuchi K
    J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28133789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presepsin values as markers of severity of sepsis.
    Aliu-Bejta A; Atelj A; Kurshumliu M; Dreshaj S; Baršić B
    Int J Infect Dis; 2020 Jun; 95():1-7. PubMed ID: 32251795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Value of Presepsin in Detection of Early-Onset Neonatal Sepsis.
    Ozdemir AA; Elgormus Y
    Am J Perinatol; 2017 May; 34(6):550-556. PubMed ID: 27825177
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of serum presepsin, procalcitonin, copeptin, and high-sensitivity C-reactive protein for differentiating bacterial infection from disease activity in Egyptian patients with systemic lupus erythematosus.
    AlJarhi UM; Sadek KM; Darwish EM; Elmessiery RM; Salem K; Khalil SA; Seif El Nasr SM; Kamel MF; Hesham D; Fayed A
    Clin Rheumatol; 2021 May; 40(5):1861-1869. PubMed ID: 33111183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin is a specific marker for detecting bacterial infection in patients with rheumatoid arthritis.
    Sato H; Tanabe N; Murasawa A; Otaki Y; Sakai T; Sugaya T; Ito S; Otani H; Abe A; Ishikawa H; Nakazono K; Kuroda T; Nakano M; Narita I
    J Rheumatol; 2012 Aug; 39(8):1517-23. PubMed ID: 22753652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome.
    Shozushima T; Takahashi G; Matsumoto N; Kojika M; Okamura Y; Endo S
    J Infect Chemother; 2011 Dec; 17(6):764-9. PubMed ID: 21560033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial.
    Masson S; Caironi P; Spanuth E; Thomae R; Panigada M; Sangiorgi G; Fumagalli R; Mauri T; Isgrò S; Fanizza C; Romero M; Tognoni G; Latini R; Gattinoni L;
    Crit Care; 2014 Jan; 18(1):R6. PubMed ID: 24393424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.